市场调查报告书
商品编码
1465966
显影剂市场:按类型、程序、给药途径、应用、最终用户、适应症分类 - 2024-2030 年全球预测Contrast Media Market by Type, Procedure, Route Of Administration, Application, End-user, Disease Indication - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年显影剂市场规模为36.7亿美元,预计2024年将达40.2亿美元,2030年将达到70.4亿美元,复合年增长率为9.75%。
显影剂是用于医学影像处理的物质,可提高体内组织、器官和其他结构的可见度。它的工作原理是改变电脑断层扫描 (CT)、X 光、超音波扫描和磁振造影(MRI) 等影像处理设备与您的身体相互作用的方式。透过增加所得影像的对比度,这些试剂可以提供更清晰的测试区域影像,有助于准确诊断和评估各种疾病。诊断影像技术的不断创新正在推动新型显影剂的开发。然而,由于显影剂的潜在副作用,越来越多的患者安全担忧阻碍了显影剂采用。先进显影剂製造程序的整合和奈米颗粒的新兴渗透在影像处理程序中提供了卓越的性能,为显影剂市场的扩张提供了有利可图的机会。
主要市场统计 | |
---|---|
基准年[2023] | 36.7亿美元 |
预测年份 [2024] | 40.2亿美元 |
预测年份 [2030] | 70.4亿美元 |
复合年增长率(%) | 9.75% |
类型:对准确诊断方式的需求增加了碘显影剂的使用
钡显影剂主要用于胃肠道 (GI) 影像,包括胃、肠和食道。根据测试部位,这些化合物可以口服或直肠给药。钆基显影剂覆盖胃肠道内壁,透过突显溃疡、息肉和肿瘤等异常情况,有效提供胃肠道的详细影像。钆基显影剂主要用于磁振造影(MRI),以增强影像清晰度和细节。这些显影剂提高了身体各部位的血管、发炎、肿瘤和肿瘤血管的可见度。钆在神经、肌肉骨骼和心血管成像中特别有用。含碘药物广泛用于电脑断层扫描 (CT)、血管造影术和造影。这些药物通常透过静脉注射,并以其透过与周围组织不同的方式吸收或散射 X 射线来增强不同身体结构或血管内液体之间的对比度的能力而闻名。碘显影剂可用于观察血管、辨识肿瘤、规划内科和外科治疗。微气泡显影剂是专门设计的超音波影像的试剂,用于增强体内血液和体液的对比。充满气体的微气泡透过静脉注射,对于心臟和血管的诊断成像特别有用。微气泡显影剂可以使血流、心臟功能可视化,并检测肝臟和其他器官的异常。
应用:介入性放射线显影剂采用率高
介入性心臟病学中的显影剂对于增强基于导管的手术期间心血管解剖和病理学的可视化至关重要。这些介质可以清楚地显示冠状动脉,从而更容易诊断冠状动脉疾病和评估病变的严重程度。它对于提供即时影像也至关重要,这些影像可以作为支架置入和球囊血管成形术的指南,并且可以作为介入性心臟病专家的判断依据。在介入放射学中,显影剂在影像引导下进行的微创手术中增强了器官、血管和组织的可见度。这些应用包括肿瘤栓塞术(使用显影剂来阐明肿瘤的血管解剖结构并辅助标靶治疗)、显影剂来可视化需要扩大的狭窄血管)以及各种静脉结构。 。在放射学中,显影剂对于增强放射线照片、 电脑断层扫描和 MRI 影像、提高不同身体部位之间的对比度以及帮助诊断疾病和病症非常重要。在电脑断层扫描中,碘造影显影剂勾勒出血管轮廓并突出显示感兴趣的区域,如腹部、骨盆和大脑,有效诊断感染疾病、发炎疾病、癌症和血管疾病。在 MRI 检查中,钆基显影剂用于增加异常组织和正常组织之间的对比度,这对于神经性大脑状况、肌肉骨骼异常和肿瘤评估等详细评估非常有用。
区域洞察
美洲,特别是美国和加拿大,先进医学影像技术的采用率很高。美国是医疗创新中心,旨在减少副作用和提高影像清晰度的新配方专利数量迅速增加。加拿大显影剂市场受益于成熟的医疗保健系统和政府促进诊断影像研究的倡议。美国消费者的购买行为受到对品质和安全的重视以及对早期诊断益处的高度认识的影响。亚太地区,特别是中国、日本和印度,已成为显影剂的重要成长市场。不断增加的医疗基础设施、对疾病早期诊断的认识以及人口老化的加剧正在推动亚太地区对显影剂的需求。在中国,最近旨在提高显影剂安全性和有效性的专利凸显了该国的研发努力。日本以其强大的医疗保健系统而闻名,并优先考虑创新的成像技术,这鼓励了先进的造影显影剂使用。印度显影剂市场的特点是增加对医疗保健的投资,并专注官民合作关係(PPP)以加强诊断服务。在欧洲、中东和非洲(Europe、Middle East、Africa),欧洲国家重点加强利用高端技术的诊断影像服务,情况多元。与媒体生产和使用相比,该地区正在积极采用更环保的做法,反映出人们对环境永续性和病人安全的认识不断增强。在医疗基础设施快速发展的中东,由于对医疗设施的投资以及对研究和创新的重视,对显影剂的需求不断增加。由于市场开拓、医疗成本不断上升以及人们对非侵入性诊断方法的认识不断增强,非洲显影剂市场具有扩张潜力。
FPNV定位矩阵
FPNV定位矩阵对于评估显影剂市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对显影剂市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动以及突破性产品开发的见解。
1.显影剂市场规模及预测如何?
2.在显影剂市场的预测期内,我们应该考虑投资哪些产品和应用?
3.显影剂市场的技术趋势和法规结构是什么?
4.显影剂市场主要厂商的市场占有率是多少?
5. 进入显影剂市场的合适型态和策略手段是什么?
[190 Pages Report] The Contrast Media Market size was estimated at USD 3.67 billion in 2023 and expected to reach USD 4.02 billion in 2024, at a CAGR 9.75% to reach USD 7.04 billion by 2030.
Contrast media are substances used in medical imaging to enhance the visibility of tissues, organs, and other structures inside the body. They work by altering how imaging tools, such as computed tomography (CT), X-rays, ultrasound scans, and magnetic resonance imaging (MRI), interact with the body. By improving the contrast of the images obtained, these agents help provide a clearer picture of the area being examined, aiding in the accurate diagnosis and assessment of various conditions. The increasing innovations in imaging technologies are boosting the development of new contrast agents. However, the rising patient safety concerns due to potential adverse reactions to contrast agents hinder the adoption of contrast media. Integration of advanced contrast media manufacturing procedures and the emerging penetration of nanoparticles offering superior performance in imaging procedures offer remunerative opportunities for the expansion of the contrast media market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.67 billion |
Estimated Year [2024] | USD 4.02 billion |
Forecast Year [2030] | USD 7.04 billion |
CAGR (%) | 9.75% |
Type: Rising use of iodinated contrast media owing to the demand for accurate diagnostic modalities
Barium-based contrast media are primarily used in gastrointestinal (GI) imaging, including stomach, intestines, and esophagus exams. These compounds are ingested orally or administered rectally, depending on the area of interest. They effectively provide detailed images of the GI tract by coating the lining and highlighting abnormalities such as ulcers, polyps, or tumors. Gadolinium-based contrast agents are primarily utilized in Magnetic Resonance Imaging (MRI) to enhance the clarity and detail of the images. These agents improve the visibility of blood vessels, inflammation, tumors, and the vascularity of tumors in various body parts. Gadolinium is particularly beneficial in neurological, musculoskeletal, and cardiovascular imaging. Iodinated contrast media are widely used in computed tomography (CT) scans, angiography, and venography. These agents are typically injected intravenously and are known for their ability to enhance the contrast between different body structures or fluids within vessels by absorbing or scattering X-rays differently than surrounding tissues. Iodinated contrast media are invaluable in visualizing blood vessels, identifying tumors, and planning medical or surgical treatment. Microbubble contrast media are specially designed agents used in ultrasound imaging to enhance the contrast of blood or fluids within the body. These gas-filled microbubbles are injected intravenously and are particularly useful in cardiac and vascular imaging. Microbubble contrast media enable the visualization of blood flow, the function of the heart, and the detection of abnormalities in the liver and other organs.
Application: High adoption of contrast media in interventional radiology
Contrast media in interventional cardiology are pivotal for enhancing the visualization of cardiovascular anatomy and pathology during catheter-based procedures. These media allow for the clear delineation of coronary arteries, facilitating the diagnosis of coronary artery disease and assessing lesion severity. They are indispensable in guiding stent placement or balloon angioplasty by providing real-time images that inform the interventional cardiologist's decisions. In interventional radiology, contrast media enhances the visibility of organs, blood vessels, and tissues during minimally invasive procedures conducted under image guidance. These applications include tumor embolization, where the contrast helps define the vascular anatomy of tumors for targeted treatment; vascular angioplasty, with contrast media delineating narrowed vessels needing dilation; and venous sampling, which enables the differentiation of various venous structures. In radiology, contrast media are crucial in enhancing radiographs, CT scans, and MRI images, improving the contrast between different body parts to help diagnose diseases and conditions. In CT scans, iodinated contrast media outline blood vessels and highlight areas of interest in the abdominal and pelvic region, brain, and more, effectively diagnosing infections, inflammatory conditions, cancers, and vascular diseases. In MRI scans, gadolinium-based contrast agents are employed to increase the contrast between abnormal and normal tissue, making them invaluable in the detailed evaluation of neurological brain conditions, musculoskeletal anomalies, and assessment of tumors.
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high adoption rate of advanced medical imaging technologies. The United States, being a hub for medical innovation, has seen a surge in patents related to novel contrast media formulations aiming for reduced side effects and improved imaging clarity. The contrast media market in Canada benefits from a well-established healthcare system and government initiatives promoting research in diagnostic imaging. Customer purchasing behavior in American countries is influenced by a strong emphasis on quality and safety and a high level of awareness about the benefits of early diagnosis. The Asia Pacific region, particularly China, Japan, and India, is emerging as a significantly growing market for contrast media. The increasing healthcare infrastructure, awareness regarding early disease diagnosis, and a growing aging population drive the demand for contrast media in the Asia-Pacific region. In China, recent patents aimed at enhancing the safety and efficacy of contrast agents highlight the country's commitment to research and development. Japan, known for its robust healthcare system, prioritizes innovative imaging technologies, thereby boosting the use of advanced contrast media. In India, the contrast media market is characterized by increasing investment in healthcare and a growing focus on public-private partnerships (PPPs) to enhance diagnostic services. In the EMEA region, Europe exhibits a diverse landscape, with EU countries focusing on enhancing imaging services through high-end technologies. The region actively embraces greener practices in contrast to media production and usage, reflecting a growing consciousness towards environmental sustainability alongside patient safety. The Middle East, amid its burgeoning healthcare infrastructure, shows a growing demand for contrast media driven by investments in healthcare facilities and a growing emphasis on research and innovation. The contrast media market in Africa presents potential for expansion owing to its untapped markets, increasing healthcare expenditure, and rising awareness about non-invasive diagnostic methods.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Contrast Media Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contrast Media Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare Co., Ltd., Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Contrast Media Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contrast Media Market?
3. What are the technology trends and regulatory frameworks in the Contrast Media Market?
4. What is the market share of the leading vendors in the Contrast Media Market?
5. Which modes and strategic moves are suitable for entering the Contrast Media Market?